Germany | Bayern

Zurück zur Suche

Internationale Partnersuche

Innovation & Technologie Angebot

Membrane-targeting lipid supplements for quality increase of in-vitro models

Country of Origin: Italy
Reference Number: TOIT20160310001
Publication Date: 10 March 2016


An Italian biotech company provides a technology for membrane standardization of cultured cells in order to create more reliable experimental models that are closer to their corresponding in-vivo tissues. The technology aims at improving the quality of experimental models used in biological laboratories through the upgrade of the cell culture technology. The company is looking for research and technical industry partners for beta-testing, product development and adaptation to specific needs.


An Italian biotech company established in 2010 and headquartered in Italy proposes the use of its products for membrane standardization of cultured cells, in order to create experimental models more reliable and closer to their corresponding in-vivo tissues. 
The team has heterogeneous and cross competences and skills in membrane lipidomics, lipid and membrane biology, lipid metabolism and cultured cells.

The company leads the cell culture technology a step foward, by envisaging the cell membrane network and its lipid composition as a cornerstone of cell physiology. The customized lipid supplements for in-vitro cells are able to improve valuable biological parameters such as membrane quality, cell physiology, cell stemness and differentiation capacity, virus and protein production, scaffold affinity, transfection, cryopreservation, etc.

The company proposes the use of its products for shaping the membrane lipid composition of cultured cells, in order to create experimental models more reliable and closer to their corresponding in-vivo tissues. The products are tailor-made lipid supplements, that will allow cell culture users to achieve significant scientific benefits and significant operational savings of money.

In addition, the company combines an analysis service in order to integrate its product pipeline with monitoring data of the variation of cell culture membrane lipid composition. Such service includes a statistical study and a lipidomic comparison of results with up-to-date scientific literature, through the use of a proprietary database.

They are looking for companies and research centers of the biotech sector to act as beta-testers, and for performing research and technical industrial cooperation for products development and adaptation to specific needs.

Advantages and Innovations

This technology helps cell culture users in achieving significant scientific benefits. The technology is suitable for all cell culture uses, from basic scientific research to drug development and pre-clinical trials. Thanks to this technology, membrane lipidomics and behaviour of cultured cells will be closer to their in-vivo counterparts, allowing to create more reliable models with increased performances. The use of this technology will reduce the variability factor in experiments conducted both in the same laboratory and in different ones.

Stage Of Development

Already on the market

Requested partner

- Type of partner sought: beta-testers, research and industrial partners.
- Specific area of activity of the partner: basic research, drug efficacy and toxicology, stem cell research, any area which makes use of in-vitro models (in particular, great interest in epatocytes and stem cells).
- Task to be performed by the partner sought: testing, research and industrial cooperation for products development, adaptation to specific needs.

Kooperationsanfrage stellen